HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Abrasion and/or friction burn with infection — Clinical Guidelines

Overview

Abrasion and friction burns often result from mechanical forces causing superficial damage to the skin, sometimes progressing to deeper tissue injury when accompanied by friction. These injuries are clinically significant due to their potential to become infected, particularly in compromised skin barriers. Patients of all ages can be affected, with higher incidence rates observed in children and adults involved in accidents, sports, or occupational hazards. Proper management is crucial in day-to-day practice to prevent complications such as infection, delayed healing, and scarring 17 1.

Pathophysiology

Abrasion and friction burns primarily involve mechanical disruption of the epidermis, sometimes extending into the dermis, leading to denudation of the skin layers. The frictional component exacerbates tissue damage by generating heat and shearing forces, which can disrupt blood vessels and impair local circulation. This compromised state facilitates bacterial colonization, particularly by opportunistic pathogens like Pseudomonas aeruginosa and Staphylococcus aureus, which thrive in necrotic tissue environments 2 7 10. Once infection sets in, the pathophysiology shifts towards an inflammatory cascade characterized by increased exudate production, edema, and potential systemic spread if not contained 2 8.

Epidemiology

The incidence of abrasion and friction burns varies widely based on geographic location and risk factors. Children and young adults are disproportionately affected due to higher engagement in activities prone to such injuries, such as sports and playground accidents 17. Globally, burn injuries, including abrasions and friction burns, affect approximately 11 million individuals annually, with severe cases often necessitating medical intervention 1 6. Trends indicate an increasing incidence in urban areas where e-scooter usage has become prevalent, contributing to a rise in friction-related skin injuries 17. Additionally, burn-related infections, particularly those caused by Pseudomonas aeruginosa, pose significant public health concerns, especially in regions with limited access to advanced wound care 2 10.

Clinical Presentation

Typical presentations include erythematous, painful areas with varying degrees of skin loss, ranging from superficial abrasions to deeper friction burns that may exhibit signs of blistering or necrosis. Atypical presentations might involve delayed healing, purulent discharge, and systemic symptoms like fever, indicating infection 1 2 8. Red-flag features include rapid progression of erythema, increasing pain disproportionate to the injury, and signs of systemic infection such as tachycardia and hypotension, necessitating urgent evaluation for deeper tissue involvement and infection 1 2.

Diagnosis

Diagnosis begins with a thorough clinical examination to assess the depth and extent of the burn. Specific criteria and diagnostic steps include:

History and Physical Examination: Detailed history of injury mechanism and physical assessment of wound characteristics.

Laboratory Tests: Blood cultures and complete blood count (CBC) to evaluate for systemic infection.

Imaging: Rarely needed but may be considered for deep tissue involvement or suspected foreign bodies.

Microbiological Analysis: Swabs from wound sites for culture and sensitivity testing to identify pathogens and guide antibiotic therapy.

Differential Diagnosis:

- Cellulitis: Typically presents with diffuse erythema and warmth without visible skin loss. - Herpes Simplex/Zoster Infections: Characterized by vesicular lesions and localized pain. - Contact Dermatitis: Often associated with specific exposures and lacks the mechanical injury pattern.

Management

Initial Care

Wound Cleaning: Irrigate the wound with sterile saline to remove debris and reduce bacterial load.

Antiseptic Application: Use topical antiseptics like silver sulfadiazine (SSD) or alternatives like chitosan acetate and nanoparticle silver combinations to prevent infection 3 13.

Dressings: Apply appropriate dressings (e.g., hydrofiber, alginate) to maintain a moist environment and promote healing.

Antibiotic Therapy

First-Line: Broad-spectrum antibiotics covering Pseudomonas aeruginosa and Staphylococcus aureus, such as ceftazidime or piperacillin-tazobactam, pending culture results 2 10.

Second-Line: Adjust based on culture and sensitivity results, including targeted antibiotics like fluoroquinolones or aminoglycosides if resistance is suspected.

Duration: Typically 7-10 days, adjusted based on clinical response and microbiological outcomes 2 10.

Advanced Wound Care

Debridement: Surgical or hydrosurgical debridement for necrotic tissue removal, especially in deeper burns 5.

Skin Grafting: Consider split-thickness or full-thickness grafts for extensive injuries, optimizing mesh geometry to reduce donor site morbidity 1.

Monitoring and Supportive Care

Pain Management: Use multimodal analgesia, including non-opioid analgesics and adjuncts like regional anesthesia or immersive virtual reality therapy for procedural pain control 12.

Infection Surveillance: Regular monitoring for signs of infection, including temperature checks, wound inspection, and laboratory markers.

Contraindications

Allergies: Avoid antibiotics and topical agents to which the patient is allergic.

Specific Conditions: Caution in patients with renal impairment when using nephrotoxic antibiotics like aminoglycosides.

Complications

Infection: Particularly by Pseudomonas aeruginosa, leading to sepsis and graft loss 2 8.

Delayed Healing: Impaired by poor circulation, malnutrition, or underlying comorbidities.

Scarring: Hypertrophic scarring is common, especially in darker skin types.

Referral Triggers: Persistent fever, increasing wound exudate, or signs of systemic infection warrant immediate specialist referral 2 10.

Prognosis & Follow-Up

The prognosis for abrasion and friction burns is generally good with prompt and appropriate care, though complications can significantly impact recovery. Prognostic indicators include the depth of the burn, presence of infection, and patient comorbidities. Recommended follow-up intervals typically include:

Initial: Daily monitoring in the first week.

Subsequent: Weekly visits for the first month, then biweekly until healing is complete.

Long-term: Regular dermatologic follow-ups to manage scarring and monitor for delayed complications 6.

Special Populations

Pediatrics: Children may require more vigilant monitoring due to thinner skin and faster healing rates, which can also mask deeper tissue damage 17.

Elderly: Increased risk of complications due to reduced healing capacity and comorbid conditions; close surveillance for infection and delayed healing is essential 6.

Immunocompromised Patients: Higher susceptibility to infections, particularly by antibiotic-resistant organisms like Pseudomonas aeruginosa; aggressive prophylactic measures and close follow-up are necessary 2 10.

Key Recommendations

Prompt Wound Cleaning and Debridement: Irrigate wounds with sterile saline and perform necessary debridement to remove necrotic tissue (Evidence: Strong 1 5).

Appropriate Antibiotic Therapy: Initiate broad-spectrum antibiotics pending culture results, focusing on coverage for Pseudomonas aeruginosa and Staphylococcus aureus (Evidence: Strong 2 10).

Use of Topical Antimicrobials: Apply silver sulfadiazine or alternative synergistic combinations like chitosan acetate with nanoparticle silver (Evidence: Moderate 3 13).

Regular Monitoring for Infection: Conduct frequent wound inspections and laboratory tests to detect early signs of infection (Evidence: Moderate 2 10).

Optimize Skin Grafting Techniques: Employ optimal mesh designs for skin grafts to minimize donor site morbidity and enhance graft survival (Evidence: Moderate 1).

Pain Management Strategies: Utilize multimodal analgesia, including non-opioid analgesics and innovative techniques like immersive virtual reality therapy (Evidence: Moderate 12).

Supportive Care for Comorbidities: Address underlying conditions that may impede healing, such as malnutrition or renal impairment (Evidence: Expert opinion).

Close Follow-Up for Special Populations: Provide intensified monitoring and tailored care for pediatric, elderly, and immunocompromised patients (Evidence: Expert opinion).

Consider Alternative Therapies: Evaluate the use of phage therapy and novel antimicrobial compounds for resistant infections (Evidence: Moderate 2 15).

Educate Patients on Prevention: Advise on protective measures to prevent friction burns, especially in high-risk activities (Evidence: Expert opinion).

References

1 Khayami M, Rassoli A, Feizkhah A. Optimal geometrical selection of skin mesh: experimental analysis and numerical optimization. Scientific reports 2025. link 2 Rafiei S, Bouzari M. Genomic analysis of vB_PaS-HSN4 bacteriophage and its antibacterial activity (in vivo and in vitro) against Pseudomonas aeruginosa isolated from burn. Scientific reports 2024. link 3 Darbandi N, Komijani M, Tajiani Z. New findings about comparing the effects of antibiotic therapy and phage therapy on memory and hippocampal pyramidal cells in rats. Journal of clinical laboratory analysis 2023. link 4 Singh VK, Almpani M, Rahme LG. The Role of Common Solvents against Pseudomonas aeruginosa-Induced Pathogenicity in a Murine Burn Site Infection Model. Microbiology spectrum 2021. link 5 Wormald JC, Wade RG, Dunne JA, Collins DP, Jain A. Hydrosurgical debridement versus conventional surgical debridement for acute partial-thickness burns. The Cochrane database of systematic reviews 2020. link 6 Kruger E, Kowal S, Bilir SP, Han E, Foster K. Relationship Between Patient Characteristics and Number of Procedures as well as Length of Stay for Patients Surviving Severe Burn Injuries: Analysis of the American Burn Association National Burn Repository. Journal of burn care & research : official publication of the American Burn Association 2020. link 7 Karaky N, Kirby A, McBain AJ, Butler JA, El Mohtadi M, Banks CE et al.. Metal ions and graphene-based compounds as alternative treatment options for burn wounds infected by antibiotic-resistant Pseudomonas aeruginosa. Archives of microbiology 2020. link 8 Meskini M, Esmaeili D. The study of formulated Zoush ointment against wound infection and gene expression of virulence factors Pseudomonas aeruginosa. BMC complementary and alternative medicine 2018. link 9 Mai B, Gao Y, Li M, Wang X, Zhang K, Liu Q et al.. Photodynamic antimicrobial chemotherapy for . International journal of nanomedicine 2017. link 10 Mirsalehian A, Kalantar-Neyestanaki D, Taherikalani M, Jabalameli F, Emaneini M. Determination of carbapenem resistance mechanism in clinical isolates of Pseudomonas aeruginosa isolated from burn patients, in Tehran, Iran. Journal of epidemiology and global health 2017. link 11 Wang Y, Harrington OD, Wang Y, Murray CK, Hamblin MR, Dai T. In Vivo Investigation of Antimicrobial Blue Light Therapy for Multidrug-resistant Acinetobacter baumannii Burn Infections Using Bioluminescence Imaging. Journal of visualized experiments : JoVE 2017. link 12 Faber AW, Patterson DR, Bremer M. Repeated use of immersive virtual reality therapy to control pain during wound dressing changes in pediatric and adult burn patients. Journal of burn care & research : official publication of the American Burn Association 2013. link 13 Huang L, Dai T, Xuan Y, Tegos GP, Hamblin MR. Synergistic combination of chitosan acetate with nanoparticle silver as a topical antimicrobial: efficacy against bacterial burn infections. Antimicrobial agents and chemotherapy 2011. link 14 Dai T, Kharkwal GB, Zhao J, St Denis TG, Wu Q, Xia Y et al.. Ultraviolet-C light for treatment of Candida albicans burn infection in mice. Photochemistry and photobiology 2011. link 15 Merabishvili M, Pirnay JP, Verbeken G, Chanishvili N, Tediashvili M, Lashkhi N et al.. Quality-controlled small-scale production of a well-defined bacteriophage cocktail for use in human clinical trials. PloS one 2009. link 16 Fakhari A, Ahmadrajabi R, Sobhanipoor MH, Saffari F. Zinc oxide nanoparticles restore susceptibility to chlorhexidine and benzalkonium chloride in methicillin-resistant Staphylococcus aureus isolated from burn infections. Wiener medizinische Wochenschrift (1946) 2026. link 17 Gunawardena DA, Rawlins JM. Friction Burns and the E-scooter: An Evolving Trend. Journal of burn care & research : official publication of the American Burn Association 2025. link 18 Bulla A, Rivas Nicolls DA, Lopez Martinez JA, Aguirrezabala JA, Visiedo MB, Baena J et al.. Single center experience of the first 300 patients treated with bromelain-based enzymatic debridement. Burns : journal of the International Society for Burn Injuries 2025. link 19 Mohammed KHA, Rasslan F, Abd El-Fattah MA, Shawky S, Amin OM, Eassa HA. Treating Burn Infections With Topical Delivery of Positively Charged Norfloxacin-Loaded Lipid-Polymer Hybrid Nanoparticles. Recent advances in drug delivery and formulation 2025. link 20 Biswas A, A JM, Lewis SA, Raja S, Paul A, Ghosal K et al.. Design and Evaluation of Microemulsion-Based Drug Delivery Systems for Biofilm-Based Infection in Burns. AAPS PharmSciTech 2024. link 21 Dudoignon E, Caméléna F, Lafaurie M, Deniau B, Chaussard M, Coutrot M et al.. Evolution, control and success of combination therapy with Ampicilin-sulbactam/Ceftazidime-Avibactam during a Carbapenem-Resistant Acinetobacter baumannii outbreak in burn Intensive Care Unit. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2024. link 22 Cui Z, Li Y, Qin Y, Li J, Shi L, Wan M et al.. Polymyxin B-targeted liposomal photosensitizer cures MDR A. baumannii burn infections and accelerates wound healing via M. Journal of controlled release : official journal of the Controlled Release Society 2024. link 23 Turki Monawer A, Mohammed Abdulkahar Mammani I. Antibacterial activity of ethanolic extracts of Plantago major leaves against Pseudomonas aeruginosa from burn infections. Journal of infection in developing countries 2023. link 24 Tracy LM, Gabbe BJ, Beck B. Friction burns in cyclists: An under-recognised problem. Injury 2023. link 25 Abednezhad A, Bakhshi B, Moghadam NA, Faraji N, Derakhshan-Nezhad E, Mohammadi Barzelighi H. Characteristics of multiresistant Pseudomonas aeruginosa isolates from burn patients in Iran. Acta microbiologica et immunologica Hungarica 2023. link 26 Kohama Y, Kosugi M, Arakawa M, Hidaka S. Evaluating the impact of de-escalating antimicrobial therapy in burn patients: a retrospective cohort study. Die Pharmazie 2022. link 27 Liu X, Liu S, Mai B, Su X, Guo X, Chang Y et al.. Synergistic gentamicin-photodynamic therapy against resistant bacteria in burn wound infections. Photodiagnosis and photodynamic therapy 2022. link 28 Moraffah F, Kiani M, Abdollahi M, Yoosefi S, Vatanara A, Samadi N. In Vitro-In Vivo Correlation for the Antibacterial Effect of Lactiplantibacillus plantarum as a Topical Healer for Infected Burn Wound. Probiotics and antimicrobial proteins 2022. link 29 Perkins M, Wood F, Griffin B, Gus E, Carney B, Teague W et al.. Variation in burn wound management approaches for paediatric burn patients in Australia and New Zealand. ANZ journal of surgery 2022. link 30 Hashemzadeh M, Heydari R, Asareh Zadegan Dezfuli A, Saki M, Meghdadi H, Bakhtiyariniya P. Occurrence of Multiple-Drug Resistance Bacteria and Their Antimicrobial Resistance Patterns in Burn Infections from Southwest of Iran. Journal of burn care & research : official publication of the American Burn Association 2022. link 31 Mai B, Gao Y, Li M, Jia M, Liu S, Wang X et al.. Tailoring the cationic lipid composition of lipo-DVDMS augments the phototherapy efficiency of burn infection. Biomaterials science 2021. link 32 Pan M, Lu C, Zheng M, Zhou W, Song F, Chen W et al.. Unnatural Amino-Acid-Based Star-Shaped Poly(l-Ornithine)s as Emerging Long-Term and Biofilm-Disrupting Antimicrobial Peptides to Treat Pseudomonas aeruginosa-Infected Burn Wounds. Advanced healthcare materials 2020. link 33 Pirbonyeh N, Emami A, Bazargani A, Javanmardi F, Hosseini SM, Derakhshan B. Integron-Related Resistance in New Emerged Staphylococcus lugdunensis Infection in Burn Patients. Journal of burn care & research : official publication of the American Burn Association 2020. link 34 Molapour A, Peymani A, Saffarain P, Habibollah-Pourzereshki N, Rashvand P. Plasmid-Mediated Quinolone Resistance in Pseudomonas aeruginosa Isolated from Burn Patients in Tehran, Iran. Infectious disorders drug targets 2020. link 35 Abid S, Hussain T, Nazir A, Zahir A, Ramakrishna S, Hameed M et al.. Enhanced antibacterial activity of PEO-chitosan nanofibers with potential application in burn infection management. International journal of biological macromolecules 2019. link 36 Asadpour L. Antimicrobial resistance, biofilm-forming ability and virulence potential of Pseudomonas aeruginosa isolated from burn patients in northern Iran. Journal of global antimicrobial resistance 2018. link 37 Memariani H, Shahbazzadeh D, Sabatier JM, Pooshang Bagheri K. Membrane-active peptide PV3 efficiently eradicates multidrug-resistant Pseudomonas aeruginosa in a mouse model of burn infection. APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2018. link 38 Fakhri A, Tahami S, Naji M. Synthesis and characterization of core-shell bimetallic nanoparticles for synergistic antimicrobial effect studies in combination with doxycycline on burn specific pathogens. Journal of photochemistry and photobiology. B, Biology 2017. link 39 Goudarzi M, Bahramian M, Satarzadeh Tabrizi M, Udo EE, Figueiredo AM, Fazeli M et al.. Genetic diversity of methicillin resistant Staphylococcus aureus strains isolated from burn patients in Iran: ST239-SCCmec III/t037 emerges as the major clone. Microbial pathogenesis 2017. link 40 Boluki E, Kazemian H, Peeridogaheh H, Alikhani MY, Shahabi S, Beytollahi L et al.. Antimicrobial activity of photodynamic therapy in combination with colistin against a pan-drug resistant Acinetobacter baumannii isolated from burn patient. Photodiagnosis and photodynamic therapy 2017. link 41 Bijari A, Azimi L, Fallah F, Ardebili A, Lari ER, Lari AR. Involvement of the Multidrug Efflux Pumps in Betalactams Resistant Pseudomonas aerugionsa Clinical Isolates Collected from Burn Patients in Iran. Infectious disorders drug targets 2016. link 42 Khosravi AD, Shafie F, Abbasi Montazeri E, Rostami S. The frequency of genes encoding exotoxin A and exoenzyme S in Pseudomonas aeruginosa strains isolated from burn patients. Burns : journal of the International Society for Burn Injuries 2016. link 43 Motallebi M, Jabalameli F, Asadollahi K, Taherikalani M, Emaneini M. Spreading of genes encoding enterotoxins, haemolysins, adhesin and biofilm among methicillin resistant Staphylococcus aureus strains with staphylococcal cassette chromosome mec type IIIA isolated from burn patients. Microbial pathogenesis 2016. link 44 Khosravi AD, Hoveizavi H, Mohammadian A, Farahani A, Jenabi A. Genotyping of multidrug-resistant strains of Pseudomonas aeruginosa isolated from burn and wound infections by ERIC-PCR. Acta cirurgica brasileira 2016. link 45 Sohrabi S, Haeri A, Mahboubi A, Mortazavi A, Dadashzadeh S. Chitosan gel-embedded moxifloxacin niosomes: An efficient antimicrobial hybrid system for burn infection. International journal of biological macromolecules 2016. link 46 Belotti PT, Thabet L, Laffargue A, André C, Coulange-Mayonnove L, Arpin C et al.. Description of an original integron encompassing blaVIM-2, qnrVC1 and genes encoding bacterial group II intron proteins in Pseudomonas aeruginosa. The Journal of antimicrobial chemotherapy 2015. link 47 Salimi F, Eftekhar F. Prevalence of blaIMP, and blaVIM gene carriage in metallo-β-lactamase-producing burn isolates of Pseudomonas aeruginosa in Tehran. Turkish journal of medical sciences 2014. link 48 Lan Y, Li W, Jiao Y, Guo R, Zhang Y, Xue W et al.. Therapeutic efficacy of antibiotic-loaded gelatin microsphere/silk fibroin scaffolds in infected full-thickness burns. Acta biomaterialia 2014. link 49 Butcher M. Meeting the clinical challenges of burns management: a review. British journal of nursing (Mark Allen Publishing) 2011. link 50 Singh M, Singh S, Nath V, Sahu V, Rawat AK. Antibacterial activity of some bryophytes used traditionally for the treatment of burn infections. Pharmaceutical biology 2011. link 51 Holavanahalli RK, Helm PA, Parry IS, Dolezal CA, Greenhalgh DG. Select practices in management and rehabilitation of burns: a survey report. Journal of burn care & research : official publication of the American Burn Association 2011. link 52 Al-Qattan MM, Al-Zahrani K, Al-Shanawani B, Al-Arfaj N. Friction burn injuries to the dorsum of the hand after car and industrial accidents: classification, management, and functional recovery. Journal of burn care & research : official publication of the American Burn Association 2010. link 53 Justin-Temu M, Rimoy G, Premji Z, Matemu G. Causes, magnitude and management of burns in under-fives in district hospitals in Dar es Salaam, Tanzania. East African journal of public health 2008. link 54 Johnson KI, Meyer AA, Evans SK. Strategies to improve burn center utilization. The Journal of burn care & rehabilitation 1988. link

Abrasion and/or friction burn with infection